Valproate Efficacy in Cocaine-Bipolar Comorbidity

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Bipolar Disorder, Cocaine Dependence

In brief

This proposal will test the efficacy of a promising pharmacological approach for the treatment of comorbid cocaine dependence and bipolar disorder. We propose a randomized, double blind, placebo controlled 12-week trial to test the efficacy of Divalproex sodium (Valproate) plus treatment as usual compared to placebo plus treatment as usual in decreasing cocaine use and stabilizing mood symptoms among patients with comorbid cocaine dependence and bipolar disorder. Treatment as usual includes the use of lithium carbonate for mood stabilization plus supportive psychosocial treatment.

Key facts

Study ID
NCT00240110
Run by
University of Miami
People needed
152
Starts
2006-03-01
Expected to finish
2014-03-01
Last updated by the study team
2016-10-17

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.